Patents give booster dose to Suven Life

DALAL STREET SPIKES

These patents are valid until 2023 and will be useful in the treatment of cognitive impairment associated with neuro-degenarative disorders like Alzheimer's disease, Parkinson's disease, schizophrenia and Huntington's disease. The total quantity traded today was 1.69 lakh shares.